In Brief This Week: Luminex; Quest Diagnostics; Rosetta Genomics; Med BioGene | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Luminex this week said that it xTAG Gastrointestinal Pathogen Panel has been CE Marked. The PCR-based panel simultaneously detects and identifies 15 parasitic, bacterial, and viral pathogens, accounting for 95 percent of all gastrointestinal infections. The test can run on the firm's Magpix and Luminex 100/200 systems.

Luminex said that it intends to file for regulatory approval of the panel in the US and Canada, but did not provide a timeline for such filings.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.